On 1/22/2008
ohiomike wrote:
My wife and I are new to this conference (she is the patient)and still have much to learn about noids. She has been on Sando since she was first diagnosed in late 2005 and (based on my understanding) is one of the fortunate few who have experienced a major decrease in liver mets since beginning Sando. She started with the usual regimine of sub Q for several weeks and then went to LAR which she has continued with. We just learned about the pump and are currently looking into switching to that for (presumably) better control & optimization of Octrotide level.My question is this: We have heard from several sources that, eventually, Sando becomes less effective. Is this true? If so, how long does it take for this to happen? Does "less effective" mean less effective in controling carcinoid syndrome, tumor growth, or both? My wife has never had carcinoid syndrome. Am I correct in assuming that the pump should help lesson the likely-hood that the Sando will become less effective by maintaining the optimum level of Octreotide.
Thanks very much for any and all input the Group may have.
Mike Hardy
So ..she has "non-functioning carcinoid" but is continuing to take sando lar. I , recently, was told that I have non-functioning! Have been told to get off sando lar!?? Who is your oncologists? My concern is that sando lar should be taken regardless of non-functioning carcinoid. ????? I have heard that there is a decrease in effectiveness. My understanding is that Dr. Woltering is looking into this. bill